{"id":"https://openalex.org/W1989197319","doi":"https://doi.org/10.1161/circulationaha.110.980623","title":"Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans","display_name":"Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans","publication_year":2011,"publication_date":"2011-04-19","ids":{"openalex":"https://openalex.org/W1989197319","doi":"https://doi.org/10.1161/circulationaha.110.980623","mag":"1989197319","pmid":"https://pubmed.ncbi.nlm.nih.gov/21502572"},"language":"en","primary_location":{"id":"doi:10.1161/circulationaha.110.980623","doi":"https://doi.org/10.1161/circulationaha.110.980623","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circulationaha.110.980623","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103012993","display_name":"Martin Ungerer","orcid":"https://orcid.org/0000-0002-2811-4283","observed_orcids":["https://orcid.org/0000-0002-2811-4283","https://orcid.org/0000-0002-5198-3399"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Ungerer","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","Medicore GmbH, Greifenberg (P.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Medicore GmbH, Greifenberg (P.S.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033089402","display_name":"Kai Rosport","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kai Rosport","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","Medicore GmbH, Greifenberg (P.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Medicore GmbH, Greifenberg (P.S.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108440044","display_name":"Andreas B\u00fcltmann","orcid":"https://orcid.org/0009-0002-4443-8904","observed_orcids":["https://orcid.org/0009-0002-4443-8904"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas B\u00fcltmann","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056063742","display_name":"Richard Piechatzek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Richard Piechatzek","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","Medicore GmbH, Greifenberg (P.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Medicore GmbH, Greifenberg (P.S.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000831734","display_name":"Kerstin Uhland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kerstin Uhland","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","Medicore GmbH, Greifenberg (P.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Medicore GmbH, Greifenberg (P.S.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078288670","display_name":"Peter Schlieper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Schlieper","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","Medicore GmbH, Greifenberg (P.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Medicore GmbH, Greifenberg (P.S.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079002169","display_name":"Meinrad Gawaz","orcid":"https://orcid.org/0000-0003-1124-9592","observed_orcids":["https://orcid.org/0000-0003-1124-9592"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Meinrad Gawaz","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","Medicore GmbH, Greifenberg (P.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Medicore GmbH, Greifenberg (P.S.)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028259882","display_name":"G\u00f6tz M\u00fcnch","orcid":"https://orcid.org/0000-0002-5552-4923","observed_orcids":["https://orcid.org/0000-0002-5552-4923"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"G\u00f6tz M\u00fcnch","raw_affiliation_strings":["From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Corimmun GmbH (formerly Procorde GmbH), Martinsried (M.U., K.R., A.B., K.U., G.M.); ABX-CRO GmbH (formerly Medifacts GmbH), G\u00f6rlitz (R.P.); Medicore GmbH, Greifenberg (P.S.); and Medizinische Klinik Innere Medizin III, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany (M.G.)","institution_ids":["https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I8087733"],"apc_list":null,"apc_paid":null,"fwci":9.6147,"has_fulltext":false,"cited_by_count":245,"citation_normalized_percentile":{"value":0.98397351,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"123","issue":"17","first_page":"1891","last_page":"1899"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glycoprotein-vi","display_name":"glycoprotein VI","score":0.7770000100135803},{"id":"https://openalex.org/keywords/fc-fusion-protein","display_name":"Fc fusion protein","score":0.8100000023841858},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.9089999794960022},{"id":"https://openalex.org/keywords/collagen-induced-platelet-aggregation","display_name":"collagen-induced aggregation","score":0.9610000252723694},{"id":"https://openalex.org/keywords/platelet-adhesion","display_name":"platelet adhesion","score":0.7699999809265137},{"id":"https://openalex.org/keywords/hemostasis","display_name":"hemostasis","score":0.7590000033378601},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9390000104904175},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9340000152587891},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4970000088214874},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8849431872367859},{"id":"https://openalex.org/C2778589496","wikidata":"https://www.wikidata.org/wiki/Q487937","display_name":"Hemostasis","level":2,"score":0.7090584635734558},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.671283483505249},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6690115928649902},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6305100321769714},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6128381490707397},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5955947637557983},{"id":"https://openalex.org/C2777265216","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Antiplatelet drug","level":4,"score":0.5843212008476257},{"id":"https://openalex.org/C2779216453","wikidata":"https://www.wikidata.org/wiki/Q489957","display_name":"Bleeding time","level":4,"score":0.5465353727340698},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5190516114234924},{"id":"https://openalex.org/C3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","level":3,"score":0.41889306902885437},{"id":"https://openalex.org/C2780009322","wikidata":"https://www.wikidata.org/wiki/Q7202246","display_name":"Platelet adhesiveness","level":4,"score":0.41607820987701416},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.3616027235984802},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.34819674491882324},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29703986644744873},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.20263215899467468},{"id":"https://openalex.org/C2993802102","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet aggregation","level":3,"score":0.17718848586082458}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003094","descriptor_name":"Collagen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003094","descriptor_name":"Collagen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003094","descriptor_name":"Collagen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006487","descriptor_name":"Hemostasis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006487","descriptor_name":"Hemostasis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006487","descriptor_name":"Hemostasis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/circulationaha.110.980623","doi":"https://doi.org/10.1161/circulationaha.110.980623","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circulationaha.110.980623","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:21502572","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21502572","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6899999976158142}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1421247184","https://openalex.org/W1972832497","https://openalex.org/W1982309326","https://openalex.org/W1990906644","https://openalex.org/W1990947862","https://openalex.org/W2006494011","https://openalex.org/W2023198638","https://openalex.org/W2025510606","https://openalex.org/W2039881470","https://openalex.org/W2047800110","https://openalex.org/W2057372364","https://openalex.org/W2068307892","https://openalex.org/W2082403298","https://openalex.org/W2082776243","https://openalex.org/W2087291640","https://openalex.org/W2102056068","https://openalex.org/W2102706327","https://openalex.org/W2103583352","https://openalex.org/W2122871792","https://openalex.org/W2129425642","https://openalex.org/W2129507256","https://openalex.org/W2129958400","https://openalex.org/W2130083671","https://openalex.org/W2156927593","https://openalex.org/W2158745909","https://openalex.org/W2162118648","https://openalex.org/W2165043805","https://openalex.org/W2165122118","https://openalex.org/W2169387542"],"related_works":["https://openalex.org/W2968384601","https://openalex.org/W2377309094","https://openalex.org/W73713807","https://openalex.org/W1888373868","https://openalex.org/W2314261010","https://openalex.org/W3193563134","https://openalex.org/W4235863923","https://openalex.org/W2141526147","https://openalex.org/W2605301109","https://openalex.org/W2006780955"],"abstract_inverted_index":{"BACKGROUND:":[0],"Blocking":[1],"of":[2,23,78,97,110,113,232],"glycoprotein":[3,36],"VI-dependent":[4],"pathways":[5],"by":[6,47],"interfering":[7],"in":[8,51,59,80,176,189],"vascular":[9,49],"collagen":[10,50],"sites":[11],"is":[12,214],"commonly":[13],"seen":[14],"as":[15,28],"an":[16,20],"attractive":[17],"target":[18],"for":[19,147],"antiplatelet":[21,220],"therapy":[22],"acute":[24],"atherosclerotic":[25],"diseases":[26],"such":[27],"myocardial":[29],"infarction":[30],"or":[31,53,102,157,173,194],"stroke.":[32],"Revacept":[33,79,114,125,213],"(soluble":[34],"dimeric":[35],"VI-Fc":[37],"fusion":[38],"protein)":[39],"has":[40],"been":[41],"shown":[42],"to":[43,56,70,140],"reduce":[44],"platelet":[45,134,162,233],"adhesion":[46],"blocking":[48],"plaques":[52],"erosion":[54],"and":[55,76,119,122,146,181,217],"be":[57],"safe":[58,216],"preclinical":[60],"studies.":[61],"A":[62],"dose-escalating":[63],"clinical":[64],"phase":[65,208],"I":[66,209],"study":[67,210],"was":[68,136],"performed":[69],"assess":[71],"the":[72,130],"safety,":[73],"tolerability,":[74],"pharmacokinetics,":[75],"pharmacodynamics":[77],"humans.":[81],"METHODS":[82],"AND":[83],"RESULTS:":[84],"In":[85,154],"a":[86,93,116,120,215,223],"first-in-humans":[87],"study,":[88],"30":[89],"healthy":[90],"men":[91],"received":[92],"single":[94],"intravenous":[95],"administration":[96],"10,":[98],"20,":[99],"40,":[100],"80,":[101],"160":[103],"mg":[104],"Revacept.":[105],"The":[106],"serum":[107],"concentration-time":[108],"courses":[109],"each":[111],"dosage":[112],"showed":[115],"narrow":[117],"variation":[118],"concentration":[121],"time":[123],"dependence.":[124],"did":[126],"not":[127],"significantly":[128],"affect":[129],"bleeding":[131],"time.":[132],"Collagen-induced":[133],"aggregation":[135,163,234],"dose-dependently":[137],"inhibited":[138],"up":[139],"48":[141],"hours":[142],"at":[143],"lower":[144],"doses":[145],"7":[148],"days":[149],"after":[150],"higher":[151],"dose":[152],"levels.":[153],"contrast,":[155],"ADP-":[156],"thrombin":[158],"receptor":[159],"activating":[160],"peptide-dependent":[161],"remained":[164],"unaltered.":[165],"There":[166,184],"were":[167,185,204],"no":[168,186],"relevant":[169],"drug-related":[170,174,187],"adverse":[171],"events":[172],"changes":[175,188],"laboratory":[177],"parameters":[178,196],"(biochemistry,":[179],"hematology,":[180],"coagulation":[182],"parameters).":[183],"blood":[190],"pressure,":[191],"pulse":[192],"rate,":[193],"ECG":[195],"(including":[197],"24-hour":[198],"Holter":[199],"monitoring).":[200],"No":[201],"anti-Revacept":[202],"antibodies":[203],"detected.":[205],"CONCLUSION:":[206],"This":[207],"demonstrated":[211],"that":[212],"well-tolerated":[218],"new":[219],"compound":[221],"with":[222,228],"clear":[224],"dose-dependent":[225],"pharmacokinetic":[226],"profile":[227],"specific,":[229],"dose-related":[230],"inhibition":[231],"despite":[235],"completely":[236],"unaltered":[237],"general":[238],"hemostasis.":[239],"CLINICAL":[240],"TRIAL":[241],"REGISTRATION:":[242],"URL:":[243,249],"www.clinicaltrials.gov.":[244],"Unique":[245],"identifier:":[246],"NCT":[247],"01042964.":[248],"eudract.ema.europa.eu.":[250],"Identifier:":[251],"2005-004656-12.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":27},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":15}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}